Gastrointestinal Remedies - US - April 2012

Sales of gastrointestinal (GI) remedies grew considerably in 2009, in part because of strong demand for over-the-counter (OTC) versions of prescription remedies such as Prilosec OTC. This growth, however, decelerated in 2010 and 2011. While significant opportunities exist in the category, it is evident that at this point in history brands must work harder than ever to garner customer loyalty and differentiate if they want to succeed in this challenging marketplace. This is especially true for national brands, as they have been losing share to private label in recent years.

In order to provide facts and insights that can help companies succeed in this challenging marketplace, Mintel has published this report which addresses the following questions:

How have sales of antacids, laxatives, stomach remedies and diarrheal remedies fluctuated in recent years and how are they likely to change in the future?
How are macro-level economic and health-related factors driving sales of GI remedies?
What are the leading brands in the category and how are they performing in comparison to private label?
How widespread are GI problems in the U.S. and what types of conditions are most common?
What types of strategies are used most often by Americans to manage GI health?
What types of remedies are most popular with Americans and what brands are they most likely to use?
How do various factors, such as recommendations from a friend or coworker, impact brand decisions?